FPMAJ “Not Opposed” to Company Requirements for Receiving Price Maintenance Premium: Kamoya

June 20, 2017
FPMAJ Drug Pricing Affairs Chief Yoshiaki Kamoya Yoshiaki Kamoya, chairman of the Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) pricing affairs committee, said on June 16 that the FPMAJ “is not opposed” to the proposed revision of company requirements...read more